| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 09/10/2004 | WO2004056727A8 Process of making chalcone derivatives |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | WO2004000215A3 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 09/10/2004 | WO2003087092A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease |
| 09/09/2004 | US20040176615 Forming calcium salt from ester |
| 09/09/2004 | US20040176614 Process for the preparation of indole derivatives and intermediates of the process |
| 09/09/2004 | US20040176613 Method for preparing n-($g(v)-bromoalkyl)phthalimides |
| 09/09/2004 | US20040176612 Method for preparing n-($g(v)-bromoalkyl)phthalimides |
| 09/09/2004 | US20040176610 Indolone oxazolidinones and derivatives thereof |
| 09/09/2004 | US20040176462 NPY Y5 antagonist |
| 09/09/2004 | US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 09/09/2004 | US20040176436 Tryptophanyl-esters and their N-acyl derivatives for preventing and treating diseases caused or aggravated by oxidation processes |
| 09/09/2004 | US20040176435 example compound: (3S)-3-(1-Benzothien-7-yloxy)-N-methyl-3-phenyl-1-propanamine oxalate; depression, OCD, anxiety, memory loss, urinary incontinence, conduct disorders, ADHD, obesity, alcoholism, smoking cessation and pain |
| 09/09/2004 | US20040176426 farnesoid X receptor; to mitigate and thereby treat hypercholesterolemia; antagonists, which block the negative feedback downregulation of cyp7a expression produced by certain cholic acids |
| 09/09/2004 | US20040176419 particularly chronic obstructive pulmonary disease (COPD), asthma or a related pulmonary disease such as chronic bronchitis or allergic rhinitis |
| 09/09/2004 | US20040176392 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition |
| 09/09/2004 | US20040176388 example compound: cis-1-[(2-chloro-3-trifluoromethylphenyl)acetyl]-6-(3,4,5-trimethylpiperazin-1-yl)indole; treatment of CNS and other disorders |
| 09/09/2004 | US20040176384 inhibit Tissue factor expression and vascular permeability factor expression in cancer cells and in vascular endothelial cells in the tumor microenvironment; low toxicity to normal vascular endothelial cells |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040173777 Fluorescent diketopyrrolopyrrole analogues |
| 09/08/2004 | EP1454898A1 Novel phenylalanine derivative |
| 09/08/2004 | EP1453803A2 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 09/08/2004 | EP1453802A1 2, 7 - substituted carbazoles and oligomers, polymers and co-polymers thereof |
| 09/08/2004 | EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 09/08/2004 | EP1453800A2 Protein kinase inhibitors |
| 09/08/2004 | EP1453792A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
| 09/08/2004 | EP1453790A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453512A1 Acetylene derivatives having mglur 5 antagonistic activity |
| 09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 09/08/2004 | EP1453497A1 Use for the treatment of gastroesophageal reflux disease |
| 09/08/2004 | EP1235571B1 Use of melatonin for treating androgenetic and diffuse female type alopecia |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | EP1084114B1 Isothiazole derivatives useful as anticancer agents |
| 09/08/2004 | EP1064021B1 Use of cysteinprotease inhibitors for the manufacture of a medicament for prevention and treatment of brain tissue impairment due to hypertensive encephalopathy or encephalothlipsis. |
| 09/08/2004 | EP0944581A4 Process of preparing substituted acrylamides |
| 09/08/2004 | EP0729455B1 Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/08/2004 | CN1527816A New indole derivatives with 5-HT6 receptor affinity |
| 09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
| 09/08/2004 | CN1526689A Diphenyl anthracene derivate and organic electroluminescent apparatus using diphenyl anthracene derivate |
| 09/08/2004 | CN1165537C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 09/08/2004 | CN1165303C DNA binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| 09/08/2004 | CN1165293C New oral formulation for 5-HT4 agonists or antagonists |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787569 Therapeutic guanidines |
| 09/07/2004 | US6787559 Sulfonamide compounds |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787538 Hormone replacement therapy; agonists, antagonists; antiestrogens with little to no intrinsic estrogenicity |
| 09/07/2004 | US6787535 Indole derivatives with 5HT6 receptor affinity |
| 09/07/2004 | US6787347 Microorganisms for use in the generation of preferential cyclopentene |
| 09/07/2004 | CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases |
| 09/02/2004 | WO2004074282A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them |
| 09/02/2004 | WO2004074242A2 Halogenated oxime derivatives and the use thereof as latent acids |
| 09/02/2004 | WO2004073709A1 Antimicrobial agents |
| 09/02/2004 | WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/02/2004 | WO2004073606A2 Sulfonamide derivatives as ppar modulators |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | WO2003099786A3 Aromatic sulfones and their medical use |
| 09/02/2004 | WO2003049698A8 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171849 Halogenation a 4-amino-2-hydroxybutyric acid ; cyclization; in aqueous solution |
| 09/02/2004 | US20040171846 Process for nitrating photocleavable compounds |
| 09/02/2004 | US20040171833 Ligands for metals and improved metal-catalyzed processes based thereon |
| 09/02/2004 | US20040171670 Neurological diseases and disorders; such as 3-fluoro-10,11-dihydro-5-(2-aminoethyl)-5H-dibenzo[a,d]cycloheptene |
| 09/02/2004 | US20040171665 Novel polymorphic form IV and solvate; precipitation from ethyl acetate |
| 09/02/2004 | US20040171634 Anticancer, antitumor agents, antiarthritic agents |
| 09/02/2004 | US20040171626 having good to very good inhibitory activity against HCV polymerase; hepatitis C virus |
| 09/02/2004 | US20040170924 Oxime ester photoiniators having a combined structure |
| 09/02/2004 | US20040170863 Organic electroluminescent devices using double-spiro organic compounds |
| 09/02/2004 | CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/02/2004 | CA2515984A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them |
| 09/02/2004 | CA2512883A1 Sulfonamide derivatives as ppar modulators |
| 09/02/2004 | CA2511979A1 Halogenated oxime derivatives and the use thereof as latent acids |
| 09/01/2004 | EP1452527A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 09/01/2004 | EP1452526A1 Indole compound and medicinal use thereof |
| 09/01/2004 | EP1452525A1 Amide derivatives and drugs |
| 09/01/2004 | EP1452522A2 Novel compounds and compositions as protease inhibitors |
| 09/01/2004 | EP1451881A1 Organic light emitting diode devices using thermostable hole-injection and hole-transport compounds |
| 09/01/2004 | EP1451195A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 09/01/2004 | EP1451185A1 Indole-2-carboxamides as factor xa inhibitors |
| 09/01/2004 | EP1451179A1 Pyrrole synthesis |
| 09/01/2004 | EP1451167A1 Phenylalkynes |
| 09/01/2004 | EP1451154A2 Inhibitors of cytosolic phospholipase a2 |
| 09/01/2004 | EP1228024B1 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 09/01/2004 | CN1525975A Tert. alkylphenoxy substituted polycyclic compounds |
| 09/01/2004 | CN1525957A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525855A Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases |
| 09/01/2004 | CN1164574C Phenoxypropylamine compounds |
| 08/31/2004 | US6784323 Enantioselective transformation of α,β-unsaturated aldehydes using chiral organic catalysts |
| 08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 08/31/2004 | US6784200 Such as n-3-(cis-2,3,3a,4,9,9a-hexahydro-1h-benz(f)isoindol-2-yl)-n-prop-1-yl-n'-3 -acetylphenylurea for prevention of inflammatory diseases (asthma and allergies) |
| 08/31/2004 | US6784193 Mutilin derivatives and their use as antibacterials |
| 08/31/2004 | US6784183 Diphenylurea compounds |
| 08/31/2004 | US6784179 Tetracyclic derivatives, process of preparation and use |
| 08/31/2004 | US6784172 Acylation of 1,4-benzodiazepines, followed by nitrosation, reduction, imination with a cyclopentanone, cyclization, reduction and deacylation |
| 08/29/2004 | WO2004035047A1 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity |
| 08/29/2004 | CA2501172A1 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity |
| 08/26/2004 | WO2004072087A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |